Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
Clinical trial NCT00434239 · UNKNOWN
Trial details
- NCT number
- NCT00434239
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2011-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.